A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants

Phase 1 Recruiting 86 enrolled Jazz Pharmaceuticals Jazz Pharmaceuticals Ireland Limited · collab

RandomizedSequentialDouble-blindTreatment

Summary

This is a Phase 1, double-blind, sponsor-unblinded, randomized, placebo-controlled study designed to characterize the safety, tolerability, and PK of JZP047 in healthy participants following single-ascending doses of study intervention. Additionally, the effect of food on PK following a single dose of JZP047 will be assessed through comparison of PK between the fed and fasted states.

Timeline

Start: 2026-02-03
Primary completion: 2026-07-05
Completion: 2026-07-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	JZP047	Unknown	—	—

Indications

No indication recorded.